Regulation of mevalonate 5-pyrophosphate decarboxylase in HeLa cells. Inhibition of enzymatic protein synthesis by serum lipoproteins

Int J Biochem Cell Biol. 1997 Jul;29(7):1037-41. doi: 10.1016/s1357-2725(97)00019-8.

Abstract

Mevalonate 5-pyrophosphate decarboxylase (EC 4.1.1.33) has been considered as a secondary site of regulation of cholesterogenesis. Because of this, we have studied the regulation of decarboxylase in HeLa cells by serum lipoproteins in the cell culture medium. A first group of experiments was performed with cells grown in Eagle's medium with 10% foetal calf serum. The specific activity of decarboxylase was increased when whole foetal calf serum was replaced with lipoprotein-poor serum. This increase was clearly reduced in the presence of cycloheximide. Addition of serum lipoproteins to a medium containing lipoprotein-poor serum led to a clear decrease in the decarboxylase activity. An identical decrease was observed after the addition of lipoproteins alone or in combination with cycloheximide. These results suggest for the first time that the effect of serum lipoproteins on decarboxylase activity should be a decrease in the rate of enzymatic protein synthesis, and corroborate the important role of reactions other than those catalysed by 3-hydroxy-3-methylglutaryl-CoA reductase in the regulation of cholesterogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Proteins / pharmacology*
  • Carboxy-Lyases / biosynthesis*
  • Cholesterol / metabolism
  • Culture Media
  • Gene Expression Regulation, Enzymologic*
  • HeLa Cells
  • Humans
  • Lipoproteins / pharmacology*

Substances

  • Blood Proteins
  • Culture Media
  • Lipoproteins
  • Cholesterol
  • Carboxy-Lyases
  • pyrophosphomevalonate decarboxylase